Board Meeting Intimation for Approval Of IND-AS Compliant Standalone Un-Audited Financial Results For The Quarter Ended On 30Th June 2026 Pursuant To Regulation 33 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.
04-Aug-2026 | Source : BSESharma East India Hospitals & Medical Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve 1. To approve IND-AS compliant Standalone Un-audited Financial Results along with Limited Review Report for the quarter ended on 30th June 2026 pursuant to regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015. 2. Any other business with permission of Chair and with the consent of a majority of the Directors present in the Meeting including include at least one Independent Director.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
09-Jul-2026 | Source : BSECertificate under Reg 74(5) of SEBI (DP) Regulations 2018 for the quarter ended June 30-06-2026.
Closure of Trading Window
22-Jun-2026 | Source : BSEIntimation of closure of trading window for the quarter ended June 30 2026.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






